The presence of three factors for the prognosis has been suggested, whether there is a palpable mass of the<unk> , whether lymph nodes are positive and whether there is an underlying malignant cancer. If there is none of these, the five- and 10-year survival is 85% and 80% respectively, with adjuvant chemotherapy even 95% and 90%. If there is a palpable mass, it is 32% and 31% respectively, with adjuvant chemotherapy (40% and 35%). Positive lymph-nodes have been positively associated with a palpable mass and affect the prognosis to be now just 28% survival after 10 years (vs 79% without palpable mass and without affected lymph-nodes). Involvement of the lymph nodes does not directly cause any harm, but is merely an indicator of systemic spread. Furthermore, patients with an identifiable associated underlying breast tumor have a survival rate of 38-40% at five years and a survival rate of 22-33% at 10 years. The death rate of metastatic breast carcinoma in patients with mammary<unk> 's<unk>  and underlying cancer is 61.3%, with a 10-year cumulative survival rate of 33%.
Paget's disease of the breast
Hereditary lobular breast cancer
Breast eczema
Adenomyoepithelioma of the breast
Medullary breast carcinoma
Mucinous carcinoma of the breast
Duct ectasia of breast
Papillomatosis of breasts